Kinetics of the Solution-Mediated Polymorphic Transformation of Organic Compounds

被引：7
|
作者：
Wantha, Lek [1 ]
机构：
[1] Burapha Univ, Fac Engn, Dept Chem Engn, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand
来源：
CURRENT PHARMACEUTICAL DESIGN | 2018年 / 24卷 / 21期
关键词：
Polymorphism; organic compound; crystallization from solution; kinetics; solution-mediated polymorphic transformation; process modelling; L-GLUTAMIC ACID; ACTIVE PHARMACEUTICAL INGREDIENTS; POPULATION BALANCE MODEL; DRUG-DELIVERY SYSTEM; FORM III PIRACETAM; SOLID-STATE; NUCLEATION KINETICS; CRYSTALLIZATION BEHAVIOR; DISSOLUTION KINETICS; PHASE-TRANSFORMATION;
D O I：
10.2174/1381612824666180601093228
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Polymorphism is a behavior of a substance to crystallize into more than one district crystal structures. Preferential formation of a polymorph depends strongly on the kinetics of the relevant mechanisms. Solution-mediated polymorphic transformation is an important mechanism in crystallization of organic compounds from solution. Knowing its kinetics allows us to understand the process and control the polymorphic formation. In this review, concepts, kinetics, and process modeling of crystallization and solution-mediated polymorphic transformation are examined and summarized.
引用
收藏
页码：2383 / 2393
页数：11
相关论文
共 50 条
  • [31] Solution-mediated phase transformation: Significance during dissolution and implications for bioavailability
    Greco, Kristyn
    Bogner, Robin
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (09) : 2996 - 3018
  • [32] Biorelevant Media Slows the Solution-Mediated Phase Transformation of Amorphous Spironolactone
    Kleppe, Mary S.
    Haskell, Roy J.
    Bogner, Robin H.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) : 426 - 435
  • [33] Investigation of a solution-mediated phase transformation of pranlukast DMF solvate to hemihydrate
    Hong, Minghuang
    Chen, Jingyan
    Zhou, Hui
    Xu, Hao
    Ren, Guobin
    CRYSTAL RESEARCH AND TECHNOLOGY, 2017, 52 (06)
  • [34] Influence of impurities on the solution-mediated phase transformation of an active pharmaceutical ingredient
    Mukuta, T
    Lee, AY
    Kawakami, T
    Myerson, AS
    CRYSTAL GROWTH & DESIGN, 2005, 5 (04) : 1429 - 1436
  • [35] Solution-Mediated Phase Transformation of Haloperidol Mesylate in the Presence of Sodium Lauryl Sulfate
    Greco, Kristyn
    Bogner, Robin
    AAPS PHARMSCITECH, 2011, 12 (03): : 909 - 916
  • [36] Population Balance Modeling of the Solution-Mediated Transformation of DL-Methionine Polymorphs
    Wantha, Lek
    Flood, Adrian E.
    CHEMICAL ENGINEERING & TECHNOLOGY, 2013, 36 (08) : 1313 - 1319
  • [37] Investigation of Solution-Mediated Phase Transformation of Cefuroxime Acid to Its Acetonitrile Solvate
    Wang, Guan
    Ma, Youguang
    Wang, Yongli
    Hao, Hongxun
    Jiang, Yang
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (12) : 1820 - 1825
  • [38] Solution-Mediated Phase Transformation on Crystal Facets of Carbamazepine-Saccharin Cocrystals
    Omori, Maaya
    Sugano, Kiyohiko
    CRYSTAL GROWTH & DESIGN, 2021, 21 (11) : 6237 - 6244
  • [39] Solution-Mediated Phase Transformation Processes of Amorphous Iohexol: Mechanisms and Its Applications
    Shen, Shudie
    Wang, Xiaoning
    Dong, Chenglin
    Zhao, Wenli
    Wang, Yanfei
    Zhu, Liang
    CRYSTAL GROWTH & DESIGN, 2025, 25 (03) : 519 - 532
  • [40] Solution-Mediated Phase Transformation of Haloperidol Mesylate in the Presence of Sodium Lauryl Sulfate
    Kristyn Greco
    Robin Bogner
    AAPS PharmSciTech, 2011, 12 : 909 - 916
12345